ARCHIVES

NIH institute directors, in response to question from Sen. Arlen Specter, say Bush Administration’s stem cell research policy is harmful to NIH leadership in science.

This article is from The Cancer Letter archive.

Vol. 31 No. 14 | April 8, 2005

Download PDF Visit The Full Archive

Related Articles

Lederle Scientists Report Powerful New Anticancer Agent

July 31, 1987

Rosenberg Begins Trial To Immunize Patient against Tumor

October 11, 1991

Large Study Finds No Survival Benefit Associated With Removal Of Ovaries

January 30, 2009

NCI Shakeup Possibilities Grow; Marc Lippman To Head Lombardi Center; DCT Could Lose CTEP

March 11, 1988

In Brief: Gift To St. Jude: $1 Million McDonald’s Ticket; Leitch Elected President, ACS Texas Division

January 5, 1996

Group Chairs Urge NCI to Limit Authority of Steering Committees That Determine Which Trials Get Funded

August 5, 2011